Carmichael Hill & Associates’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.17K | Hold |
11
| – | – | ﹤0.01% | 594 |
|
|
2024
Q2 | $2.27K | Sell |
11
-3
| -21% | -$620 | ﹤0.01% | 592 |
|
|
2024
Q1 | $3.79K | Sell |
14
-5
| -26% | -$1.36K | ﹤0.01% | 560 |
|
|
2023
Q4 | $4.49K | Hold |
19
| – | – | ﹤0.01% | 549 |
|
|
2023
Q3 | $3.72K | Hold |
19
| – | – | ﹤0.01% | 554 |
|
|
2023
Q2 | $4K | Hold |
19
| – | – | ﹤0.01% | 553 |
|
|
2023
Q1 | $3.84K | Hold |
19
| – | – | ﹤0.01% | 559 |
|
|
2022
Q4 | $4.14K | Hold |
19
| – | – | ﹤0.01% | 529 |
|
|
2022
Q3 | $4K | Hold |
19
| – | – | ﹤0.01% | 573 |
|
|
2022
Q2 | $4K | Buy |
19
+3
| +19% | +$632 | ﹤0.01% | 565 |
|
|
2022
Q1 | $5K | Hold |
16
| – | – | ﹤0.01% | 566 |
|
|
2021
Q4 | $6K | Hold |
16
| – | – | ﹤0.01% | 559 |
|
|
2021
Q3 | $7K | Hold |
16
| – | – | ﹤0.01% | 529 |
|
|
2021
Q2 | $6K | Sell |
16
-1
| -6% | -$375 | ﹤0.01% | 539 |
|
|
2021
Q1 | $5K | Hold |
17
| – | – | ﹤0.01% | 541 |
|
|
2020
Q4 | $4K | Hold |
17
| – | – | ﹤0.01% | 550 |
|
|
2020
Q3 | $4K | Hold |
17
| – | – | ﹤0.01% | 512 |
|
|
2020
Q2 | $3K | Hold |
17
| – | – | ﹤0.01% | 510 |
|
|
2020
Q1 | $2K | Hold |
17
| – | – | ﹤0.01% | 526 |
|
|
2019
Q4 | $3K | Buy |
+17
| New | +$3K | ﹤0.01% | 535 |
|